通过综合基因方法探索偏头痛的禁用药物和相应的向基因
Nan Wang1, Weixuan Liang2, Zhuofeng Wen3
1Department of Anesthesiology, Nanjing Jiangning Hospital, Nanjing, China.
Brain and behavior
|November 20, 2025
概括
利尿剂和氨酸-血管新生素系统的药物是对偏头痛和带有光环的偏头痛的禁忌. 与这些药物相关的特定基因为偏头痛亚型提供了新的预防策略.
科学领域:
- 药物基因组学 药物基因组学
- 神经学 神经学
- 遗传学 是一个遗传学.
背景情况:
- 偏头痛是一种复杂的神经疾病,具有各种亚型.
- 确定禁用药物及其遗传点对于患者安全和有效的治疗策略至关重要.
研究的目的:
- 为了确定对偏头痛和其亚型的药物禁用.
- 为了确定这些禁用药物的基因.
- 为开发偏头痛预防策略提供见解.
主要方法:
- 孟德尔随机化 (MR) 使用英国生物银行和FinnGen GWAS数据来识别禁忌药物.
- 全转录组关联研究 (TWAS) 和药物数据库,以识别目标基因.
- 使用基于总结数据的门德尔随机化 (SMR) 和TWAS和 Colocalization (INTACT) 的集成进行敏感性分析.
- 脑组织TWAS以确认组织特定的基因关联.
主要成果:
- 利尿剂和氨酸-血管新生素系统药物与偏头痛风险增加有关.
- 针对偏头痛和带有光环的偏头痛分别确定了37个和22个向基因.
- 关键基因 (例如SERPINC1,ALMS1,ZKSCAN8P1) 在大脑组织中被验证与偏头痛亚型的关联.
结论:
- 利尿剂和氨酸-血管新生素系统的药物是对偏头痛和带有光环的偏头痛的禁忌.
- 特定的基因 (例如BLM,C12orf76,GPATCH4,PAM,SERPINC1,ALMS1,NCF2,SLC12A1,ZKSCAN8P1) 被确定为这些禁用药物的标.
- 这些发现为偏头痛预防和个性化治疗方法提供了新的途径.
相关概念视频
01:28Human Genetics
1.4K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.4K
01:26Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K